Brief: Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical Trial
15/12/2025 01:04
Dec 15 (Reuters) - Imricor Medical Systems Inc IMR.AX: INSTITUTIONAL REVIEW BOARD APPROVED UVA HEALTH'S ENROLMENT IN CO'S VISABL-AFL CLINICAL TRIAL Further company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion